Skip to main content

Forte Biosciences, Inc.

FBRXDelisted Aug 27, 2026
Industry
Pharmaceutical Preparations
SEC CIK
0001419041

Forte Biosciences, Inc. was delisted on Aug 27, 2026; its insiders filed their last Form 4 on Aug 27, 2026; 86 institutions reported holding it in 13F filings for Q2 2026, worth $432.7M in total; no superinvestor held it.

13F holders, Q1 2025

Institutional positions in Forte Biosciences, Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
30
+4 vs. Q4 2024
Shares held
5.17M
+895.5K (+20.9%) vs. Q4 2024
Total value
$40.4M
−$56.7M (−58.4%) vs. Q4 2024
New holders
6
8 more added
Sold out
2
4 more reduced

Compare with Q4 2024: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting FBRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2025: 30 institutions
Q1 2021: 62 institutionsQ2 2021: 75 institutionsQ3 2021: 58 institutionsQ4 2021: 52 institutionsQ1 2022: 52 institutionsQ2 2022: 40 institutionsQ3 2022: 33 institutionsQ4 2022: 34 institutionsQ1 2023: 31 institutionsQ2 2023: 31 institutionsQ3 2023: 31 institutionsQ4 2023: 35 institutionsQ1 2024: 33 institutionsQ2 2024: 34 institutionsQ3 2024: 24 institutionsQ4 2024: 26 institutionsQ1 2025: 30 institutionsQ2 2025: 34 institutionsQ3 2025: 42 institutionsQ4 2025: 59 institutionsQ1 2026: 68 institutionsQ2 2026: 86 institutions
Value heldQ1 2025: $40.4M
Q1 2021: $273.1MQ2 2021: $289.4MQ3 2021: $12.8MQ4 2021: $11.5MQ1 2022: $5.68MQ2 2022: $3.01MQ3 2022: $2.85MQ4 2022: $3.80MQ1 2023: $3.90MQ2 2023: $3.60MQ3 2023: $11.1MQ4 2023: $15.5MQ1 2024: $13.3MQ2 2024: $10.2MQ3 2024: $4.12MQ4 2024: $97.1MQ1 2025: $40.4MQ2 2025: $130.4MQ3 2025: $155.1MQ4 2025: $314.5MQ1 2026: $350.2MQ2 2026: $432.7M
Institutions holding FBRX and their total value by quarter
QuarterHoldersValue
Q2 202686$432.7M
Q1 202668$350.2M
Q4 202559$314.5M
Q3 202542$155.1M
Q2 202534$130.4M
Q1 202530$40.4M
Q4 202426$97.1M
Q3 202424$4.12M
Q2 202434$10.2M
Q1 202433$13.3M
Q4 202335$15.5M
Q3 202331$11.1M
Q2 202331$3.60M
Q1 202331$3.90M
Q4 202234$3.80M
Q3 202233$2.85M
Q2 202240$3.01M
Q1 202252$5.68M
Q4 202152$11.5M
Q3 202158$12.8M
Q2 202175$289.4M
Q1 202162$273.1M

Institutions, Q1 2025

Shares, value and share of portfolio for each institution holding Forte Biosciences, Inc.; share changes are against Q4 2024.

Institutions holding FBRX in Q1 2025
InstitutionSharesValue% of portfolioChange in sharesAction
Janus Henderson Group PLC920,000$7.39M0.00%+920,000New
Fred Alger Management, LLC910,609$7.07M0.04%−223,335−19.7%Reduced
Tybourne Capital Management (HK) Ltd619,981$4.81M20.42%00.0%Unchanged
Ikarian Capital, LLC609,225$4.73M1.54%00.0%Unchanged
BVF Inc594,282$4.61M0.19%00.0%Unchanged
OrbiMed Advisors LLC593,088$4.60M0.11%−6,912−1.2%Reduced
Cable Car Capital LLC219,604$1.70M1.93%00.0%Unchanged
Woodline Partners LP204,822$1.59M0.01%+547+0.3%Added
AWM Investment Company, Inc.136,821$1.06M0.15%+136,821New
Boothbay Fund Management, LLC89,191$692.1K0.02%00.0%Unchanged
Vanguard Group Inc88,951$690.3K0.00%+62,557+237.0%Added
Farallon Capital Management, L.L.C.70,429$546.5K0.00%+35,429+101.2%Added
Geode Capital Management, LLC60,082$466.3K0.00%+43,205+256.0%Added
Acuta Capital Partners, LLC18,469$143.3K0.17%+330+1.8%Added
Millennium Management LLC14,605$113.3K0.00%+14,605New
BlackRock, Inc.6,803$52.8K0.00%00.0%Unchanged
Quest Partners LLC4,217$32.7K0.00%+4,217New
Garde Capital, Inc.3,960$30.7K0.00%+3,960New
Royal Bank of Canada3,342$26.0K0.00%−442−11.7%Reduced
Tower Research Capital LLC (TRC)1,792$13.9K0.00%+1,692+1,692.0%Added
UBS Group AG527$4.09K0.00%+527New
Comerica Bank155$1.20K0.00%+99+176.8%Added
Morgan Stanley151$1.17K0.00%00.0%Unchanged
Group One Trading, L.P.104$8070.00%00.0%Unchanged
Bank of America Corp46$3570.00%+36+360.0%Added
Private Trust Co NA42$3260.00%00.0%Unchanged
SBI Securities Co., Ltd.12$930.00%00.0%Unchanged
BNP Paribas Arbitrage, SA8$620.00%00.0%Unchanged
JPMorgan Chase & Co3$230.00%−2,100−99.9%Reduced
REAP Financial Group, LLC3$230.00%00.0%Unchanged
Perceptive Advisors LLC0$00.00%−95,742−100.0%Sold out
Loring Wolcott & Coolidge Fiduciary Advisors LLP0$00.00%−7−100.0%Sold out